Föreskrifter (HSLF-FS 2020:1) om ändring i Läkemedelsverkets föreskrifter (LVFS 2011:10) om förteckningar över narkotika;

1 1 Senast ändrade genom HSLF-FS 2019:23.

HSLF-FS 2020:1

– – – – – – – – – – – –

– – – – – – – – –

Anmärkning

– – – – – – – – –

nell o

I I I – – – – – – – – III – – – – P

ternati

förteckning – – – – – – – – –

In

– – – – – – – – –

– – – I– IP – – – IP I– I– I– – – – – – IV –

Svensk förteckning

– – – – – – – – –

- – – – – – – ro- – – – mid

oxa – – – – – – – – – rb -dihyd 5

l-1H-indol-3 – – – – – – – – – – – – ol-3-ka nty az -pe d – – – – – – – – – -in amid H – – – – – – -yl)-5-pentyl-2, – – – igt kemisk namn -2-yl)-1 n-2-yl)-1-(5-fluoropentyl)metyl-1-oxobutan-2-yl)-1- tyl)-1 yl)-N-(2-fenylpropan-2-yl)- an-2

– – – – arboxamid lme – – – – – – – –

Entyd

l-3-k exy nylprop – – – o – – – – – – loh k daz -(1-amino-3- -(2-fenylpropa -(2-fe – – – N-(1-adamantyl)-1-(cyklohexylmetyl)-1H- in N (cy – – – 1-(4-cyanobut 1H-indazol-3-karbox N 1H-pyrrolo[2,3-b]pyridin-3-karboxamid 2 1H-pyrido[4,3-b]indol-1-on N-(2-fenylpropan karboxamid 5-(1-cykohexen-1-yl)-5-etylbarbitursyra – – –

n E – – – – – – – – N – – – – O L C – – – – – – – – – A

ande nam

eGA IC – – – – – – -P -P – – – ndra vanligt L L

A

MY MY – – – – – – – – U U – – – –

förekomm

A-CHMINACA AB-CHMINACA CUMYL-4CN-BINACA CUMYL-5F-P7AICA C C

– – – – – – – – –

g

– – – – – – – – –

– – – – – – – – – – – –

INN-benämnin – – – – – – – – – Ämne – – Cyklobarbital –

– – – – – – – – – – – – – – – –

– – – – – – – – – – – –

– – – – – – – – – – – –

V I I – – – – – – – – – I I – – – – – – – – – – P I

– – – – – – – – – – – –

– – – – – – – – – – – –

– – – I I– – – – IP I– IP – – – I I– I – – – – IV – – –

– – – – – – – – – – – –

– – – – – – – – – – – –

]dek-1- – – – – – – 3,7 – – – – – – 1 1. .3. – – – – – – – – – – – – – – – – [3

– – – – – – yklo – – – – – –

– – – – – – -5-yl)-2-(etylamino) – – – – – – H-s-triazolo[4,3- orobutyl)-1H-indazol-3- uoropentyl)-1H-indol-3zepin l)-Ntric 9,10-didehydroergolin-8- 4-flu enty – – – – – – – – – – – – – – – – tylorop – – – – – – – – – – – – ,N,6-trie etyl-2-([1-(5-fl -kloro-6-fenyl-4 – – – 8 a][1,4]bensodia 3-(2-etylfenyl)-2-metylkinazolin-4(3H)-on N karboxamid – – – 1-(1,3-bensodioxol propan-1-on Metyl-2-[1-( karboxamido]-3,3-dimetylbutanoat 1-(5-flu yl-1H-indazol-3-karboxamid – – – 5-jodo-2,3-dihydro-1H-inden-2-amin M yl]karboxamido)-3-metylbutanoat – – –

– – – – – – – – – – – – – – – –

– – – – – – – – – – – –

– – – – – – – – – – – –

B48 – – – – – – – – – – – – – – – – Etakvalon ETH-LAD Etylon 4F-MDMB-BINACA 5F-APINACA 5F- AK 5-IAI I-AMB Ibogain – – – – – – – – – – – –

– – – – – – – – – – – –

– – – – – – – – – – – – – – – –

– – – – – – – – – – – – – Estazolam – – –

HSLF-FS 2020:1

– – – – – – – – – – – – – – – –

– – – – – – – – – – – –

– – – – – – – – – – – –

II I – – – – – – – – – – – – – – – – – – – P N

– – – – – – – – – – – –

– – – – – – – – – – – –

– – – I I– I– I – – – I– I– I– – – – II I II – – – – – – –

– – – – – – – – – – – –

– – – – – – – – – – – –

– – – – – – – – – – – –

H-indazol-3- – – – – – – – – – – – – – – – – n – – – – – – – – – ami yl-6,7-bensomorfan – – – amido]butanoat – – – -2-(piperidin-2-yl)acetat – – – – – – – – – tyl-2-[1-(pent-4-en-1-yl)- fenetyl klohexylmetyl)-1 -[2-(4-isopropoxibensyl)-5- cy etyl – – – – tylamino)cyklohexyl]-3,4- – – – – -( – – – – – – – – [1 im -( -d 2 α – – – – – – l- – – – – – – ropyl-2-fenyl y ,N-dietyl-2 et etyl-3,3-dime )-N, -(1,3-bensodioxol-5-yl)-2-(pyrrolidin-1- – – – Isop N-[2-(dime dikloro-N-(propan-2-yl)bensamid N nitro-1H-benso[d]imidazol-1-yl]etan-1-amin 5-(2-aminopropyl)indol – – – M karbonyl]amino)-3,3-dimetylbutanoat M 1H-indazol-3-karbox 1 yl)butan-1-on – – – (± N-metyl-1-(naftalen-2-yl)propan-2-amin 2’-hydroxi-2,5,9-trimet – – –

– – – – – – – – – – – – – – – – ACA – – – – – – N – – – – – – in – – – – – – – – – – – – etam n

– – – – – – – – – – – – – – – – Isopropylfenidat Isopropyl-U-47700 Isotonitazen 5-IT MDMB-CHMI MDMB-4en-PINACA MDPBP Metam – – – – – – – – – – – –

– – – – – – – – – – – – in

– – – – – – – – – – – – fetam – – – – at – – – – – – – – – etam – – – – – – M racem Metazocin –

– – – – – – – – – – – –

– – – – – – – – –

– – – – – – – – –

I II – – – – N – – – – – – – – P

– – – – – – – – –

– – – – – – – – –

– – – II I– II – – – I– I– I– I– – – – – – –

– – – – – – – – –

– – – – – – i- – – – x – – – – – – – – –

– – – – – – – – – – – – indol[2,3- – – – – – – – – –

– – – – – – robensyl)-1H-indol-3- – – – o ,3S,12bS)-3-etyl-8-meto

– – – – – – – – – – – – -fenyl-2-piperidinacetat – – – yldihydromorfin α – – – – – – ly etyl(E)-2-[(2S dol-3-karboxamido]butanoat -met – – – 6 N-[2-(dimetylamino)cyklohexyl]-N-metyl- 2H-1,3-bensodioxol-5-karboxamid Met – – – M 1,2,3,4,6,7,12,12boktahydro a]quinolizin-2-yl]-3-metoxiprop-2-enoat Metyl-3-metyl-2-[1-(pent-4-en-1-yl)-1H- in Metyl-2-[1-(cyklohexylmetyl)-1H-indol-3- karboxamido]-3-metylbutanoat Metyl-2-[1-(4-flu karboxamido]-3-metylbutanoat – – –

– – – – – – – – – – – –

– – – – – – A A – – – IC ICA – – – – – – MIC – – – CH FUB B- B- – – – – – – – – – – – – 3,4-metylendioxi- U-47700 Mitragynin MMB-022 AMB-4en-PICA MMB-CHMICA AM MMB-FUB AM – – – – – – – – –

– – – – – – – – –

– – – – enidat – – – – – – – –

– – – etylf – – – – – – – Metyldihydromorfin M – –

HSLF-FS 2020:1

– – – – – – – – – – – –

– – – – – – – – –

– – – – – – – – –

I II I I I – – – – – IV P – – – – – – – – P P N II

– – – – – – – – –

– – – – – – – – –

– – – I– I II I– I I– II – – – IN I– IP – – – – IV – –

– – – – – – – – –

- – – – – – – -N – – – - ro H lo – – – – – – – – – ik l)-1 )etyl]-4- -d ,4 – – – – ienyl – – – – -3 – – – – l] y (2-t ex – – – tylfenetylamin – – – h – – – )-on lo -1-[2- k y – – – l) – – – – – – y )c o -4(3H ,4-dime diklorofenyl)-8-metyl-8- n in d α m – – – – -metylbutyl)barbitursyra – – – – la – – – – oximet ami azoli ty n ie – – – met – – – d – – – -( tylki 2 tylbens etyl-3-(3,4- dol-3-karboxamid -[ -sec-butyl-5-etylbarbitursyra -allyl-5-(1 – – – M azabicyklo[3.2.1]oktan-2-karboxylat N-bensyl-1-pentyl-1H-indol-3-karboxamid 5 5 5-kloro-3-(4-kloro-2-metylfenyl)-2- me 2,5-dimetoxi- N-(1-adamantyl)-1-(5-fluoropenty in N-[4-( piperidyl]propionanilid – – – 3,4-dikloro-N-[2-(dimetylamino) cyklohexyl]-N-metylbensamid N me (1-pentyl-1H-indol-3-yl)(2,2,3,3- tetrametylcyklopropyl)metanon – – –

– – – – – – – – – – – –

– – – – – – – – –

– – – – – – – – –

M – – – – – – – – – – – – RTI-111 Dikloropan SDB-006 SL-164 STP DO STS-135 U-47700 U-49900 UR-144

– – – – – – – – –

– – – – – – – – –

– – – – – – – – – – – –

entanil – – – – – – – – – – Sekbutabarbital Sekobarbital Suf – –

Dessa föreskrifter träder i kraft den 11 februari 2020. Läkemedelsverket NILS GUNNAR BILLINGER Joakim Brandberg

HSLF-FS kan laddas ner via Läkemedelsverket. Webb: www.lakemedelsverket.se

Författningen kan beställas via: Norstedts Juridik 106 47 Stockholm

SVANENMÄRKET

Telefon: 08-598 191 90 E-post: kundservice@nj.se

3041 0123Trycksak

Internet: www.nj.se/offentligapublikationer

Elanders Sverige AB, 2020